We are live on ! Find out more
CEMI

Chembio diagnostics, Inc.
CEMI

Delisted

CEMI was delisted on the 27th of April, 2023.

Back to rankings

39 hedge funds and large institutions have $37.3M invested in Chembio diagnostics, Inc. in 2019 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 13 increasing their positions, 10 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

30% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 10

7% less funds holding

Funds holding: 42 → 39 (-3)

12% less capital invested

Capital invested by funds: $42.5M → $37.3M (-$5.2M)

33% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 6

Holders
39
Holders Change
-3
Holders Change %
-7.14%
% of All Funds
0.84%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
13
Reduced
10
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
NCM
Nantahala Capital Management
Connecticut
+$2.14M
2
PCM
Perkins Capital Management
Minnesota
+$983K
3
PM
Penbrook Management
New York
+$829K
4
SBH
Segall Bryant & Hamill
Illinois
+$592K
5
MAG
Millrace Asset Group
Pennsylvania
+$263K

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$4.54M
2
ACP
Acuta Capital Partners
California
-$2.24M
3
AIP
ARS Investment Partners
New York
-$985K
4
SCM
Stonepine Capital Management
Oregon
-$832K
5
CAM
Cortina Asset Management
Wisconsin
-$169K
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
26
UBS Group
Switzerland
$133K +$129K +19,840 +477%
PFC
27
Phocas Financial Corp
California
$111K – – –
WF
28
WealthTrust Fairport
Ohio
$82K – – –
DLA
29
Douglas Lane & Associates
New York
$78K – – –
Millennium Management
30
Millennium Management
New York
$73K +$85K +13,089 New
FM
31
Family Management
New York
$60K – – –
MWNA
32
Marshall Wace North America
New York
$48K +$55.9K +8,612 New
TRCT
33
Tower Research Capital (TRC)
New York
$6K -$16.4K -2,521 -68%
Royal Bank of Canada
34
Royal Bank of Canada
Ontario, Canada
$6K – – –
AG
35
Advisor Group
Arizona
$5K – – –
LTFS
36
Ladenburg Thalmann Financial Services
Florida
$3K – – –
Bank of America
37
Bank of America
North Carolina
$1K – – –
VFA
38
Valeo Financial Advisors
Indiana
$1K – – –
PCM
39
Prelude Capital Management
New York
$1K +$1.69K +260 New
Wellington Management Group
40
Wellington Management Group
Massachusetts
– -$4.54M -801,835 Closed
SCM
41
Stonepine Capital Management
Oregon
– -$832K -147,011 Closed
SSA
42
Schonfeld Strategic Advisors
New York
– -$142K -25,000 Closed
Marshall Wace
43
Marshall Wace
United Kingdom
– -$85K -15,079 Closed
SWM
44
SeaCrest Wealth Management
New York
– -$3K -500 Closed
IA
45
IFP Advisors
Florida
– -$2K -375 Closed
1
2

CEMI Hedge Fund Activity: Q1 2019 in Review

39 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Chembio diagnostics, Inc. (CEMI) for Q1 2019, worth a combined $37.3M — down 12% from $42.5M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of CEMI and 4 opened new positions — a net loss of 2 holders — while 10 trimmed existing stakes and 13 added.

The largest buyer was Nantahala Capital Management, adding an estimated $2.14M. The largest seller was Wellington Management Group, exiting entirely with an estimated $4.54M sold.

  • 39 institutional investors held Chembio diagnostics, Inc. (CEMI) as of Q1 2019, down from 42 in Q4 2018.
  • Funds reported $37.3M of Chembio diagnostics, Inc. stock for Q1 2019, down 12% quarter-over-quarter.
  • 4 funds opened new Chembio diagnostics, Inc. positions in Q1 2019 and 6 closed out, a net change of -2 holders.
  • The largest Chembio diagnostics, Inc. buyer in Q1 2019 was Nantahala Capital Management, an estimated $2.14M added.
  • The largest Chembio diagnostics, Inc. seller in Q1 2019 was Wellington Management Group, an estimated $4.54M sold.

Based on aggregated 13F filings for Q1 2019.